SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-057073
Filing Date
2023-05-08
Accepted
2023-05-08 14:14:02
Documents
1
Period of Report
2023-05-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2315019-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2315019-1_3seq1.xml 3 1524
  Complete submission text file 0001104659-23-057073.txt   3101
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 361 NEWBURY STREET SUITE 500 BOSTON MA 02115
Business Address
Averill Julianne (Reporting) CIK: 0001903770 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37544 | Film No.: 23897110